Who owns Cumberland Pharmaceuticals?
- Ticker: CPIX
- CUSIP Number: 230770109
Tip: Access positions for across all investors
Analyze quarterly positions in Cumberland Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cumberland Pharmaceuticals stock
Who bought or sold Cumberland Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 553k | $1.8M | 0% | Mar 2026 |
|
| Renaissance Technologies | 472k | $1.9M | -8% | Dec 2025 |
|
| Vanguard Group | 412k | $1.6M | 0% | Dec 2025 |
|
| Vanguard Capital Management | 362k | $1.2M | 100% | Mar 2026 |
|
| Dimensional Fund Advisors | 276k | $898k | 1% | Mar 2026 |
|
| Perceptive Advisors | 197k | $640k | -42% | Mar 2026 |
|
| Bridgeway Capital Management | 164k | $651k | -13% | Dec 2025 |
|
| Boothbay Fund Management | 128k | $415k | -1% | Mar 2026 |
|
| Geode Capital Management | 114k | $372k | 7% | Mar 2026 |
|
| J. Goldman & Co | 95k | $376k | -55% | Dec 2025 |
|
| Jane Street | 59k | $191k | 280% | Mar 2026 |
|
| Bank of New York Mellon | 59k | $190k | -19% | Mar 2026 |
|
| BlackRock | 57k | $185k | 8% | Mar 2026 |
|
| Citadel Advisors | 50k | $162k | -23% | Mar 2026 |
|
| Marshall Wace | 48k | $192k | 100% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 46k | $148k | 100% | Mar 2026 |
|
| Acadian Asset Management | 44k | $143k | 0% | Mar 2026 |
|
| Susquehanna International | 40k | $159k | 203% | Dec 2025 |
|
| Marex Group | 36k | $118k | 100% | Mar 2026 |
|
| State Street Corporation | 34k | $134k | 0% | Dec 2025 |
|
| Northern Trust | 20k | $78k | 0% | Dec 2025 |
|
| Cresset Asset Management | 20k | $63k | 11% | Mar 2026 |
|
| Two Sigma Investments | 11k | $36k | -55% | Mar 2026 |
|
| UBS Group | 5.2k | $17k | -66% | Mar 2026 |
|
| Morgan Stanley | 3.3k | $11k | 0% | Mar 2026 |
|
| Capital Advisors | 437.00 | $999.987100 | 0% | Mar 2026 |
|
| Advisor Group Holdings | 200.00 | $796.000000 | 100% | Dec 2025 |
|
| Royal Bank of Canada | 127.00 | $0 | 100% | Mar 2026 |
|
| Wells Fargo & Company | 100.00 | $325.000000 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 2.00 | $6.000000 | 100% | Mar 2026 |
|
| Huntington National Bank | 1.00 | $4.000000 | 0% | Dec 2025 |
|
Who sold out of Cumberland Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Heron Bay Capital Management | Dec 2025 | 29k | $116k |
| XTX Topco | Sep 2025 | 11k | $33k |
| Goss Wealth Management | Dec 2025 | 1.2k | $4.8k |
| Tower Research Capital | Sep 2025 | 787.00 | $2.5k |
| Jones Financial Companies, L.L | Sep 2025 | 600.00 | $1.9k |